Clinical Trials on Relapsed

Total 50397 results

James J. Prisciandaro
National Institute on Drug Abuse (NIDA)

Completed

Brain Imaging of Cocaine Craving in Recreational Cocaine Users

Cocaine Related Disorders

United States
Hospital Universitari Vall d'Hebron Research Institute

Completed

Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients

Cocaine Related Disorders

Spain
Butler Hospital

Completed

Interactive Voice Response (IVR) for Methadone Patients

Opioid-Related Disorders

United States
Denver Health and Hospital Authority
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Completed

Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics

Alcohol Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States
Rennes University Hospital

Terminated

Postoperative and Opioid Free Anesthesia (POFA)

Opioid-Related Disorders | Anesthesia

France
Philogen S.p.A.

Terminated

A Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Very Low-dose Cytarabine in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia, Relapsed, Adult

Germany
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Recruiting

Substance Abuse Pre-Treatment Screening Study

Alcohol Dependence | Substance Abuse | Cocaine Dependence | Opiate Dependence | Cocaine Abuse

United States
Chang Gung Memorial Hospital
National Science and Technology Council

Recruiting

Combined Relapse Prediction Model for Resectable Non-Small Cell Patients - a Prospective Clinical Feasibility Trial

Lung Cancer | Relapse/Recurrence

Taiwan
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use

Opioid Use Disorder | Alcohol Use Disorder

United States
Centre Hospitalier Universitaire de Saint Etienne

Terminated

RElapse After Allograft: Link Between LoCus of Control and QualiTy of Life (REACT)

Allograft | Post-allograft Relapse

France
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Medications Development for Drug Abuse Disorders

Opioid Dependence | Opioid Related Disorders | Opioid Addiction

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Drug Utilization Patterns for Extended Release/Long Acting Opioids and Comparator Products

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers

Drug Abuse | Opioid-related Disorders | Narcotic Abuse | Opioid Addiction
Dana-Farber Cancer Institute

Completed

Cabozantinib With Topotecan-Cyclophosphamide

Refractory Ewing Sarcoma | Refractory Osteosarcoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma

United States
Masonic Cancer Center, University of Minnesota

Completed

HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma

Refractory B-Lineage Leukemia | Relapsed B-Lineage Leukemia | Refractory B-Lineage Lymphoma | Relapsed B-Lineage Lymphoma

United States
Indivior Inc.

Completed

Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder

Opioid Use Disorder | Opioid-related Disorders

United States
ER/LA Opioid REMS Program Companies (RPC)

Unknown

Evaluation of Changes in Prescribing Behavior of ER/LA Opioid Prescribers

Drug Abuse | Opiate Addiction | Opioid Related Disorders | Narcotic Abuse
Kati Järvelä

Completed

A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery

Postoperative Pain | Opioid Related Disorders

Finland
Curis, Inc.
The Leukemia and Lymphoma Society

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditions

United States
Region Stockholm

Active, not recruiting

Safe Prescription of Opioids in Primary Care

Opioid-Related Disorders | Narcotic-Related Disorders | Addiction

Sweden
PharmaMar

Completed

Non-interventional European Study of Trabectedin + PLD in the Treatment of Relapsed Ovarian Cancer (ROC) Patients (NIMES-ROC)

Relapsed Ovarian Cancer

Spain, France, Italy, Belgium, Germany
University of Pittsburgh
National Institute on Drug Abuse (NIDA)

Completed

Opioid Dependence Treatment Therapies in Pregnancy

Pregnancy | Opioid-Related Disorders

United States
University of Oregon
National Institute on Drug Abuse (NIDA)

Not yet recruiting

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA) (ISLA)

Opioid Misuse
Western Michigan University
National Institute on Drug Abuse (NIDA); RTI International; DynamiCare Health...

Not yet recruiting

OUD Smartphone Services

Opioid-Related Disorders | Drug Abuse
PATH
London School of Hygiene and Tropical Medicine; Monash University; University... and other collaborators

Not yet recruiting

Assessing the Acceptability, Feasibility, Effectiveness and Cost-effectiveness of LADB

Opioid Dependence
Wake Forest University Health Sciences
University of North Carolina, Chapel Hill; University of Kentucky; East Carolina...

Not yet recruiting

Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids

Opioid Misuse
VA Office of Research and Development

Recruiting

A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment

Dependence, Opioid

United States
Texas Christian University
University of New Mexico; Loyola University

Recruiting

Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center (JCOIN_TCU)

Addiction, Opioid

United States
Stanford University
Patient-Centered Outcomes Research Institute

Recruiting

Integrating Support Persons Into Recovery (INSPIRE)

Opioid Addiction

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Facilitating Rapid Naltrexone Initiation

Opioid Dependence

United States
University of Maryland, Baltimore

Completed

Social Work Assistance and Stipends for Housing (SASH) (SASH)

Opioid-Related Disorders | Housing Problems

United States
Jessica Morgan
Temple University

Completed

Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section

Opioid Misuse

United States
Potomac Health Foundations

Completed

Treatment of Opioid Use: Medication Adherence Therapy (MAT-PLUS)

Opioid-Related Disorders | Opioid Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers

Opioid Misuse

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling for Primary Care Office-based Buprenorphine

Opiate Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Study of Computer-Based Treatment for Drug Dependence (RLSS)

Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
University Hospital, Clermont-Ferrand
UFR Pharmacie (Clermont-Ferrand)

Completed

Evaluation of Pharmacy Students' Perception of Opioid / Opiate Dependence (STUD_TOX)

Opioid-Related Disorders

France
University of Pennsylvania
National Institute on Drug Abuse (NIDA); St. Petersburg State Pavlov Medical...

Completed

Addiction Treatment in Russia: Oral vs. Naltrexone Implant

Opioid-Related Disorders | Heroin Dependence

United States, Russian Federation
Titan Pharmaceuticals

Completed

A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants (PRO-814)

Opioid Dependence
Acura Pharmaceuticals Inc.
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer

Completed

Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users

Opioid Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine and Naltrexone Treatment for Opioid Dependence (NAMHS-1)

Opioid Dependence

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects (YHO)

Opioid-Related Disorders | Heroin Dependence

United States
University of Pennsylvania

Completed

Remote Observed Dosing to Increase Suboxone Compliance (RODISC)

Opiate Dependence

United States

Clinical Trials on Relapsed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations